Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Merck & (MRK)

Merck closes $6.0 billion underwritten offering of seven series of notes due 2028 to 2056

Neutral Impact 3 of 5 financing Written later

On May 22, 2026, Merck & Co. closed an underwritten public offering of seven series of notes with a combined principal amount of $6.0 billion, maturing between 2028 and 2056. The filing describes the issuance terms and related legal documents but does not state how the company plans to use the proceeds.

Key points

  • Seven note series totaling $6.0 billion, from a $500 million floating rate note due 2028 to a $1 billion 5.850% note due 2056
  • Largest series is $1.5 billion of 5.200% notes due 2036
  • Notes issued under a shelf registration statement filed March 19, 2024, and an indenture dated January 6, 2010, with U.S. Bank Trust National Association as trustee

The filing

CompanyMerck & (MRK)
Form8-K, current report
Filed with the SECMay 22, 2026, 4:21 PM ET
Accession number0001628280-26-037738

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 2:16 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 22, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.